top of page
sirna hero new final white

Delivering
Innovation
to Cancer

final lab group hero

Our Mission

Developing innovative therapies that directly target the cause of cancer development, progression and treatment resistance.

We are creating a world where patients suffering from the most stubborn cancers have both safe and effective treatment options.

sirnamed-our-science-rnai-cancer-research

Our Science

SirnaMed is combining decades of experience in RNA therapeutics with a delivery platform that harnesses the power of tumor-directed delivery. Combining tumor-targeting nanoparticles with traditional chemotherapy drugs and small interfering RNA (siRNA) opens new horizons for cancer patients suffering from disease.  

News and Media

June 3, 2024

SirnaMed CEO Phong Tran speaking at the 2024 BIO International Conference

September 4-5, 2024

SirnaMed CEO Phong Tran and CMO Dr Jing-Zhou Hou attending the 2024 RNA Leaders USA

November 24, 2022

Novel Nanoparticles Deliver Innovative Cancer Chemoimmunotherapy

sirnamed-footer-innovative-biotech-solutions.jpg
bottom of page